DrugPatentWatch Database Preview
Bayer Pharms Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for BAYER PHARMS, and what generic and branded alternatives to BAYER PHARMS drugs are available?
BAYER PHARMS has twenty-nine approved drugs.
Summary for Bayer Pharms
| US Patents: | 0 |
| Tradenames: | 22 |
| Ingredients: | 21 |
| NDAs: | 29 |
Drugs and US Patents for Bayer Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Pharms | ADALAT | nifedipine | CAPSULE;ORAL | 019478-002 | Sep 17, 1986 | DISCN | No | No | Start Trial | Start Trial | |||||
| Bayer Pharms | MEZLIN | mezlocillin sodium monohydrate | INJECTABLE;INJECTION | 050549-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Bayer Pharms | MEZLIN | mezlocillin sodium monohydrate | INJECTABLE;INJECTION | 062372-004 | Mar 2, 1988 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bayer Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-006 | Jul 24, 2000 | 5,006,530 | Start Trial |
| Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-003 | Jun 26, 1997 | 5,177,080 | Start Trial |
| Bayer Pharms | NIMOTOP | nimodipine | CAPSULE;ORAL | 018869-001 | Dec 28, 1988 | 3,932,645 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
